GlassScriptPhysician profile
Tuan Tran
NPI 1356845168
$2,493.22
in general payments reported to CMS, 2019-2025
26 companies · $1,757 in 2025
The $1,757 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.43 · 2022: $198 · 2023: $106 · 2024: $370 · 2025: $1,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,869 · Travel and Lodging: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,868.73 |
| Travel and Lodging | $363.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $944.95 | 2024-2025 | |
| Teleflex LLC | $261.93 | 2025 | Titan Sgs Bailout Chuck |
| Abbott Laboratories | $192.74 | 2022-2025 | Freestyle Libre 3 |
| W. L. Gore & Associates, INC. | $132.58 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Bolton Medical INC | $131.42 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Stryker Corporation | $119.97 | 2023-2024 | Spy-Phi System, Stryker |
| Integra Lifesciences Corporation | $113.62 | 2022 | |
| Medtronic, INC. | $112.20 | 2022-2025 | Signia, Endoflip |
| Recordati_rare_diseases_inc. | $56.92 | 2025 | Isturisa |
| Baxter Healthcare | $45.52 | 2021 | |
| Ibsa Pharma INC. | $42.97 | 2022-2024 | Tirosint, Licart |
| Dilon Technologies, INC. | $38.90 | 2025 | Hemoblast Bellows |
| Becton, Dickinson and Company | $38.51 | 2025 | Phasix Mesh |
| Vertex Pharmaceuticals Incorporated | $31.65 | 2025 | |
| Histosonics, INC. | $22.96 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $22.11 | 2022 | |
| Intra-Sana Laboratories | $21.34 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Aimmune Therapeutics, INC. | $20.60 | 2025 | Zenpep |
| Novo Nordisk INC | $20.09 | 2025 | Wegovy |
| Enterra Medical, INC. | $19.49 | 2025 | |
| Alexion Pharmaceuticals, INC. | $19.47 | 2025 | Strensiq |
| Pacira Pharmaceuticals Incorporated | $19.46 | 2025 | Exparel |
| Mannkind Corporation | $16.91 | 2021 | |
| Hollister Incorporated | $16.16 | 2025 | Hollister |
| Lilly USA, LLC | $16.08 | 2025 | Mounjaro, Zepbound |
| Siemens Medical Solutions USA, INC. | $14.67 | 2025 | Magnetom Sola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tuan Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.